Skip to main content

Table 3 Medications with potentially inappropriate prescribing

From: Quality use of medicines in patients with chronic kidney disease

Medications with potentially inappropriate dose

Patients prescribed N (%)

Patients with inappropriately high dose drug

N (%)

Medications potentially contraindicated

Patients prescribed N (%)

Patients with potentially contraindicated medication N (%)

Antidiabetic Medications

Antidiabetic Medications

Vildagliptin

355 (1.2)

274 (77.2)

Dapagliflozin

296 (1.0)

245 (82.8)

Saxagliptin

205 (0.7)

117 (57.1)

Acarbose

81 (0.3)

12 (14.8)

Sitagliptin

1534 (5.3)

742 (48.4)

Exenatide

313 (1.1)

18 (5.8)

Metformin

8046 (28.0)

2885 (35.9)

Metformin

8046 (28.0)

37 (0.5)

Alogliptin

17 (0.1)

5 (29.4)

Anticoagulant Medications

Lipid Lowering Medications

Rivaroxaban

1230 (4.3)

99 (8.0)

Fenofibrate

1939 (6.7)

1346 (69.4)

Dabigatran

492 (1.7)

34 (6.9)

Rosuvastatin

8529 (29.7)

525 (6.2)

Apixaban

938 (3.3)

40 (4.3)

Antihypertensive Medications

Cardiovascular Medications

Atenolol

4832 (16.8)

1849 (38.3)

Moxonidine

1675 (5.8)

447 (26.7)

Moxonidine

1675 (5.8)

43 (2.6)

Spironolactone

3050 (10.6)

665 (21.8)

Antiarrhythmics

Bisphosphonates

Digoxin

2567 (8.9)

24 (0.9)

Alendronate

791 (2.8)

251 (31.7)

Anticoagulant Medications

Risedronate

619 (2.2)

118 (19.1)

Rivaroxaban

1230 (4.3)

237 (19.3)

Others

Dabigatran

492 (1.7)

39 (7.9)

Teriparatide

7 (0.0)

2 (28.6)

Bisphosphonates

Strontium

205 (0.7)

43 (21.0)

Clodronate

10 (0.03)

5 (50)

Dextropropoxyphene

105 (0.4)

33 (31.4)

Zoledronate

24 (0.1)

1 (4.2)

Pramipexole

523 (1.8)

100 (19.1)

Antihistamines

Probenecid

115 (0.4)

1 (0.9)

Nizatidine

283 (1.0)

170 (60.1)

   

Cimetidine

15 (0.1)

3 (20.0)

   

Cetirizine

261 (0.9)

50 (19.2)

   

Psychotropic Medications

   

Paliperidone

6 (0.02)

4 (66.7)

   

Desvenlafaxine

572 (2.0)

70 (12.2)

   

Duloxetine

846 (2.9)

87 (10.3)

   

Venlafaxine

1050 (3.7)

47 (4.5)

   

Varenicline

150 (0.5)

6 (4.0)

   

Neurological Medications

   

Tramadol

571 (2)

67 (11.7)

   

Gabapentin

341 (1.2)

30 (8.8)

   

Levetiracetam

179 (0.6)

9 (5)

   

Pregabalin

4642 (16.2)

190 (4.1)

   

Pramipexole

523 (1.8)

3 (0.6)

   

Others

   

Tolterodine

20 (0.1)

2 (10.0)

   

Solifenacin

458 (1.6)

21 (4.6)

   
  1. Codeine, Glibenclamide and Glimepiride were prescribed inappropriately in all patients and is not presented in the table; Combination medications were assessed for PIP separately